Fol. Biol. 2012, 58, 121-127
https://doi.org/10.14712/fb2012058030121
Genetic and Functional Analyses of MRAS and HNF1A Genes in Diabetes and Diabetic Nephropathy
References
1. 2009) Hepatic nuclear factor 1-α: inflammation, genetics, and atherosclerosis. Curr. Opin. Lipidol. 20, 106-111.
< , A. D., Krauss, R. M. (https://doi.org/10.1097/MOL.0b013e3283295ee9>
2. 2004) Confirmation of a susceptibility locus for diabetic nephropathy on chromosome 3q23-q24 by association study in Russian type 1 diabetic patients. Diabetes Res. Clin. Pract. 66, 79-86.
< , D. A., Savostanov, K. V., Shestakova, M. V., Chugunova, L. A., Samkhalova, M. S., Dedov, I. I., Nosikov, V. V. (https://doi.org/10.1016/j.diabres.2004.02.011>
3. 2009) New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat. Genet. 41, 280-282.
< , J., Grosshennig, A., Braund, P. S., König, I. R., Hengstenberg, C., Hall, A. S., Linsel-Nitschke, P., Kathiresan, S., Wright, B., Trégouët, D. A., Cambien, F., Bruse, P., Aherrahrou, Z., Wagner, A. K., Stark, K., Schwartz, S. M., Salomaa, V., Elosua, R., Melander, O., Voight, B. F., O’Donnell, C. J., Peltonen, L., Siscovick, D. S., Altshuler, D., Merlini, P. A., Peyvandi, F., Bernardinelli, L., Ardissino, D., Schillert, A., Blankenberg, S., Zeller, T., Wild, P., Schwarz, D. F., Tiret, L., Perret, C., Schreiber, S., El Mokhtari, N. E., Schäfer, A., März, W., Renner, W., Bugert, P., Klüter, H., Schrezenmeir, J., Rubin, D., Ball, S. G., Balmforth, A. J., Wichmann, H. E., Meitinger, T., Fischer, M., Meisinger, C., Baumert, J., Peters, A., Ouwehand, W. H., Italian Atherosclerosis, Thrombosis, and Vascular Biology Working Group, Myocardial Infarction Genetics Consortium, Wellcome Trust Case Control Consortium, Cardiogenics Consortium, Deloukas, P., Thompson, J. R., Ziegler, A., Samani, N. J., Schunkert, H. (https://doi.org/10.1038/ng.307>
4. 2001) Molecular mechanisms and clinical pathophysiology of maturity-on-set diabetes of the young. N. Engl. J. Med. 345, 971-980.
< , S. S., Bell, G. I., Polonsky, K. S. (https://doi.org/10.1056/NEJMra002168>
5. 2008) Diabetic nephropathy: mechanisms of renal disease progression. Exp. Biol. Med. (Maywood) 233, 4-11.
< , Y. S., Wada, J., Sun, L., Xie, P., Wallner, E. I., Chen, S., Chugh, S., Danesh, F. R. (https://doi.org/10.3181/0705-MR-134>
6. 2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56-65.
< , S., Willer, C. J., Peloso, G. M., Demissie, S., Musunuru, K., Schadt, E. E., Kaplan, L., Bennett, D., Li, Y., Tanaka, T., Voight, B. F., Bonnycastle, L. L., Jackson, A. U., Crawford, G., Surti, A., Guiducci, C., Burtt, N. P., Parish, S., Clarke, R., Zelenika, D., Kubalanza, K. A., Morken, M. A., Scott, L. J., Stringham, H. M., Galan, P., Swift, A. J., Kuusisto, J., Bergman, R. N., Sundvall, J., Laakso, M., Ferrucci, L., Scheet, P., Sanna, S., Uda, M., Yang, Q., Lunetta, K. L., Dupuis, J., de Bakker, P. I., O’Donnell, C. J., Chambers, J. C., Kooner, J. S., Hercberg, S., Meneton, P., Lakatta, E. G., Scuteri, A., Schlessinger, D., Tuomilehto, J., Collins, F. S., Groop, L., Altshuler, D., Collins, R., Lathrop, G. M., Melander, O., Salomaa, V., Peltonen, L., Orho-Melander, M., Ordovas, J. M., Boehnke, M., Abecasis, G. R., Mohlke, K. L., Cupples, L. A. (https://doi.org/10.1038/ng.291>
7. 2010) Effect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the ludwigshafen risk and cardiovascular health study). BMC Med. Genet. 11, 157.
< , M. E., Grammer, T. B., Renner, W., März, W. (https://doi.org/10.1186/1471-2350-11-157>
8. 1999) Allelic discrimination using fluorogenic probes and the 5’ nuclease assay. Genet. Anal. 14, 143-149.
< , K. J. (https://doi.org/10.1016/S1050-3862(98)00019-9>
9. 2011) Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats. Eur. J. Pharmacol. 653, 89-94.
< , T. M., Matafome, P. N., Nunes, E. C., da Cunha, F. X., Seiça, R. M. (https://doi.org/10.1016/j.ejphar.2010.11.029>
10. 2007) Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney Int. 71, 140-145.
< , A. M., He, B., Pitkaniemi, J., Albinsson, L., Berg, T., Sarti, C., Tuomilehto, J., Tryggvason, K. (https://doi.org/10.1038/sj.ki.5001933>
11. 1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 39, 940-945.
< , M., Angelico, M. C., Warram, J. H., Krolewski, A. S. (https://doi.org/10.1007/BF00403913>
12. 2008) Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1α are associated with C-reactive protein. Am. J. Hum. Genet. 82, 1193-1201.
< , A. P., Barber, M. J., Guan, Y., Ridker, P. M., Lange, L. A., Chasman, D. I., Walston, J. D., Cooper, G. M., Jenny, N. S., Rieder, M. J., Durda, J. P., Smith, J. D., Novembre, J., Tracy, R. P., Rotter, J. I., Stephens, M., Nickerson, D. A., Krauss, R. M. (https://doi.org/10.1016/j.ajhg.2008.03.017>
13. 2008) Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women’s Genome Health Study. Am. J. Hum. Genet. 82, 1185-1192.
< , P. M., Pare, G., Parker, A., Zee, R. Y., Danik, J. S., Buring, J. E., Kwiatkowski, D., Cook, N. R., Miletich, J. P., Chasman, D. I. (https://doi.org/10.1016/j.ajhg.2008.03.015>
14. 1989) Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N. Engl. J. Med. 320, 1161-1165.
< , E. R., Goetz, F. C., Rich, S., Barbosa, J. (https://doi.org/10.1056/NEJM198905043201801>
15. 2008) Molecular background and clinical characteristics of HNF1A MODY in a Polish population. Diabetes Metab. 34, 524-528.
< , J., Gorczynska-Kosiorz, S., Klupa, T., Cyganek, K., Wanic, K., Borowiec, M., M., Sieradzki, J., Malecki, M. T. (https://doi.org/10.1016/j.diabet.2008.05.004>
16. 2005) A genome search for genetic determinants that influence plasma fibrinogen levels. Arterioscler. Thromb. Vasc. Biol. 25, 1287-1292.
< , J. M., Almasy, L., Souto, J. C., Buil, A., Lathrop, M., Blangero, J., Fontcuberta, J. (https://doi.org/10.1161/01.ATV.0000161927.38739.6f>
17. 2008) Search for type 2 diabetes susceptibility genes on chromosomes 1q, 3q and 12q. J. Hum. Genet. 53, 314-324.
< , F., Ochiai, Y., Serizawa, M., Yanai, K., Kuzuya, N., Kajio, H., Honjo, S., Takeda, N., Kaburagi, Y., Yasuda, K., Shirasawa, S., Sasazuki, T., Kato, N. (https://doi.org/10.1007/s10038-008-0254-6>
18. US Renal Data System, USRDS (2007) Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health and Diabetes and Digestive and Kidney Disease, Bethesda (MD).
19. 2006) Genetic basis of maturityonset diabetes of the young. Endocrinol. Metab. Clin. North. Am. 35, 371-384.
< , M., Froguel, P. (https://doi.org/10.1016/j.ecl.2006.02.009>
20. 2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42, 579-589.
< , B. F., Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., Aulchenko, Y. S., Thorleifsson, G., McCulloch, L. J., Ferreira, T., Grallert, H., Amin, N., Wu, G., Willer, C. J., Raychaudhuri, S., McCarroll, S. A., Langenberg, C., Hofmann, O. M., Dupuis, J., Qi, L., Segrè, A. V., van Hoek, M., Navarro, P., Ardlie, K., Balkau, B., Benediktsson, R., Bennett, A. J., Blagieva, R., Boerwinkle, E., Bonnycastle, L. L., Bengtsson, Boström, K., Bravenboer, B., Bumpstead, S., Burtt, N. P., Charpentier, G., Chines, P. S., Cornelis, M., Couper, D. J., Crawford, G., Doney, A. S., Elliott, K. S., Elliott, A. L., Erdos, M. R., Fox, C. S., Franklin, C. S., Ganser, M., Gieger, C., Grarup, N., Green, T., Griffin, S., Groves, C. J., Guiducci, C., Hadjadj, S., Hassanali, N., Herder, C., Isomaa, B., Jackson, A. U., Johnson, P. R., Jørgensen, T., Kao, W. H., Klopp, N., Kong, A., Kraft, P., Kuusisto, J., Lauritzen, T., Li, M., Lieverse, A., Lindgren, C. M., Lyssenko, V., Marre, M., Meitinger, T., Midthjell, K., Morken, M. A., Narisu, N., Nilsson, P., Owen, K. R., Payne, F., Perry, J. R., Petersen, A. K., Platou, C., Proença, C., Prokopenko, I., Rathmann, W., Rayner, N. W., Robertson, N. R., Rocheleau, G., Roden, M., Sampson, M. J., Saxena, R., Shields, B. M., Shrader, P., Sigurdsson, G., Sparsø, T., Strassburger, K., Stringham, H. M., Sun, Q., Swift, A. J., Thorand, B., Tichet, J., Tuomi, T., van Dam, R. M., van Haeften, T. W., van Herpt, T., van VlietOstaptchouk, J. V., Walters, G. B., Weedon, M. N., Wijmenga, C., Witteman, J., Bergman, R. N., Cauchi, S., Collins, F. S., Gloyn, A. L., Gyllensten, U., Hansen, T., Hide, W. A., Hitman, G. A., Hofman, A., Hunter, D. J., Hveem, K., Laakso, M., Mohlke, K. L., Morris, A. D., Palmer, C. N., Pramstaller, P. P., Rudan, I., Sijbrands, E., Stein, L. D., Tuomilehto, J., Uitterlinden, A., Walker, M., Wareham, N. J., Watanabe, R. M., Abecasis, G. R., Boehm, B. O., Campbell, H., Daly, M. J., Hattersley, A. T., Hu, F. B., Meigs, J. B., Pankow, J. S., Pedersen, O., Wichmann, H. E., Barroso, I., Florez, J. C., Frayling, T. M., Groop, L., Sladek, R., Thorsteinsdottir, U., Wilson, J. F., Illig, T., Froguel, P., van Duijn, C. M., Stefansson, K., Altshuler, D., Boehnke, M., McCarthy, M. I., MAGIC investigators, GIANT Consortium. (https://doi.org/10.1038/ng.609>
21. 2007) Are glomerular volume differences between type 1 and type 2 diabetic patients pathologically significant? Diabetologia 50, 906-912.
< , K. E., Marshall, S. M., Bilous, R. W. (https://doi.org/10.1007/s00125-007-0624-1>
22. 2007) The M-Ras-RA-GEF-2-Rap1 pathway mediates tumor necrosis factor-α dependent regulation of integrin activation in splenocytes. Mol. Biol. Cell. 18, 2949-2959.
< , Y., Satoh, T., Tamura, T., Wei, P., Bilasy, S. E., Edamatsu, H., Aiba, A., Katagiri, K., Kinashi, T., Nakao, K., Kataoka, T. (https://doi.org/10.1091/mbc.e07-03-0250>
23. 2008) Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am. J. Hum. Genet. 83, 520-528.
< , X., Waterworth, D., Perry, J. R., Lim, N., Song, K., Chambers, J. C., Zhang, W., Vollenweider, P., Stirnadel, H., Johnson, T., Bergmann, S., Beckmann, N. D., Li, Y., Ferrucci, L., Melzer, D., Hernandez, D., Singleton, A., Scott, J., Elliott, P., Waeber, G., Cardon, L., Frayling, T. M., Kooner, J. S., Mooser, V. (https://doi.org/10.1016/j.ajhg.2008.09.012>
24. 2010) Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus. BMC Med. Genet. 11, 116.
< , D., Efendic, S., Brismar, K., Gu, H. F. (https://doi.org/10.1186/1471-2350-11-116>